Charcot-Marie-Tooth disease: a clinico-genetic confrontation

Annals of Human Genetics
N BarisicVincent Timmerman

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common neuromuscular disorder. It represents a group of clinically and genetically heterogeneous inherited neuropathies. Here, we review the results of molecular genetic investigations and the clinical and neurophysiological features of the different CMT subtypes. The products of genes associated with CMT phenotypes are important for the neuronal structure maintenance, axonal transport, nerve signal transduction and functions related to the cellular integrity. Identifying the molecular basis of CMT and studying the relevant genes and their functions is important to understand the pathophysiological mechanisms of these neurodegenerative disorders, and the processes involved in the normal development and function of the peripheral nervous system. The results of molecular genetic investigations have impact on the appropriate diagnosis, genetic counselling and possible new therapeutic options for CMT patients.

References

Oct 1, 1979·Journal of the Neurological Sciences·J Pearn, P Hudgson
Oct 1, 1990·Brain : a Journal of Neurology·A F HahnT E Feasby
Nov 1, 1990·Neuropediatrics·N BarisićD Jadro-Santel
May 1, 1989·Experimental Neurology·J M VanceM A Pericak-Vance
Oct 1, 1986·Annals of Neurology·K H FischbeckJ P Fryns
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L J JosephV P Sukhatme
Feb 1, 1985·American Journal of Medical Genetics·F S CowchockL G Jackson
Oct 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·P Fleury, G Hageman
Jan 1, 1966·The Journal of Pediatrics·L Pinsky, A M DiGeorge
Sep 1, 1967·Neurology·R N Rosenberg, A Chutorian
Oct 1, 1984·Clinical Genetics·R M Pauli
Jun 1, 1980·Brain : a Journal of Neurology·A E Harding, P K Thomas
May 1, 1994·Annals of Neurology·P J DyckA E Aronson
Dec 24, 1993·Science·J BergoffenK H Fischbeck
Dec 1, 1995·The Journal of Cell Biology·Y FengA Wandinger-Ness
Sep 1, 1995·Human Molecular Genetics·K ChristodoulouL T Middleton
Mar 1, 1996·Muscle & Nerve·V V IonasescuR Ionasescu
Jul 1, 1996·Human Molecular Genetics·V TimmermanC Van Broeckhoven
Sep 1, 1996·Human Molecular Genetics·K IsozumiT Siddique
Apr 20, 1999·Pediatric Neurology·J P PhillipsB P Garg

❮ Previous
Next ❯

Citations

Jun 24, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Marie-Capucine DupuisMichel Georges
May 14, 2010·Acta Neuropathologica·Laura CogliCecilia Bucci
Jul 12, 2012·European Journal of Human Genetics : EJHG·Paschalis NicolaouKyproula Christodoulou
Oct 10, 2013·European Journal of Human Genetics : EJHG·Hui ZhaoPhilip Van Damme
Jul 26, 2011·Nature Medicine·Constantin d'YdewalleLudo Van Den Bosch
Jul 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Weiwei HeXiang-Lei Yang
Feb 25, 2010·The Journal of Biological Chemistry·Leonardo Almeida-SouzaSophie Janssens
Oct 8, 2009·Human Molecular Genetics·Perciliz L Tan, Nicholas Katsanis
Dec 24, 2009·Human Molecular Genetics·Brett A McCrayJ Paul Taylor
Feb 1, 2012·Genes, Brain, and Behavior·J M DaleM L Garcia
Jan 21, 2011·Physiological Reviews·Alex H Hutagalung, Peter J Novick
May 7, 2011·Neuroepidemiology·J MladenovicT Pekmezovic
Apr 26, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kai ZhangChengbiao Wu
Dec 18, 2013·ELife·Madhumala K SadanandappaMani Ramaswami
Apr 21, 2009·FEBS Letters·Katarina ReisPontus Aspenström
Oct 4, 2015·Neuromuscular Disorders : NMD·Shilpa D KulkarniVarsha A Patil
Apr 2, 2013·PM & R : the Journal of Injury, Function, and Rehabilitation·Robert Rinaldi, Atul Patel
Mar 25, 2016·Human Molecular Genetics·Nikos MalissovasDimitris Beis
Sep 4, 2012·Physical Medicine and Rehabilitation Clinics of North America·Craig M McDonald
Apr 3, 2012·Progress in Neurobiology·Cecilia BucciCinzia Progida
Sep 28, 2010·Journal of the Neurological Sciences·M LuigettiM Sabatelli
Feb 16, 2010·Trends in Neurosciences·William W MotleyKenneth H Fischbeck
Jun 9, 2009·Neuromuscular Disorders : NMD·Isabella MoroniFranco Taroni
Jun 23, 2009·Lancet Neurology·Davide Pareyson, Chiara Marchesi
May 12, 2009·Experimental Neurology·Romain Cartoni, Jean-Claude Martinou
Aug 6, 2013·Annals of Neurology·Delphine Bouhy, Vincent Timmerman
Sep 30, 2010·Glia·Patrizia DacciAngelo Quattrini
Mar 2, 2012·Glia·Caroline ApraLaurence Decker
Jul 22, 2010·Glia·Maria-Jesus LatasaJose Miguel Cosgaya
Feb 3, 2015·Annals of Clinical and Translational Neurology·Alessandro Didonna, Puneet Opal
Feb 14, 2014·Neurobiology of Disease·Katrien JanssensVincent Timmerman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.